• My Account
    • Login
  • Contact Us

CodingIntel

Medical coding resources for physicians and their staff. CodingIntel was founded by consultant and coding expert Betsy Nicoletti.

  • Join Today
  • What is CodingIntel
    • About
    • Become a Member
    • FAQ
  • Pricing
  • Free Resources
    • Overview
    • Blog
    • Everyday Coding Q&A
    • Newsletter
    • Can I get paid
  • Coding Library
    • Coding Guides
    • Quick Reference Sheets
    • E/M Services
    • How Physician Services Are Paid
    • Prevention & Screening
    • Care Management & Remote Monitoring
    • Surgery, Modifiers & Global
    • Diagnosis Coding
    • New & Newsworthy
    • Speciality
    • Practice Management
    • E/M Rules Archive
  • Webinars

December 10, 2023

Drug therapy requiring intensive monitoring for toxicity

Print Friendly, PDF & Email

Question:

When auditing MDM, is there a list of drugs that are considered “drug therapy requiring intensive monitoring for toxicity?”

Answer:

This question is answered from those guidelines, but the end of the Q&A discusses the 2021 CPT changes.

This doesn’t mean other payers will follow this list. Many of the drugs on this list are given to patients chronically, as outpatients, and are not being monitored intensively.

Let’s use bronchodilators as an example. A patient with acute COPD in the ED who is receiving bronchodilators might qualify. A patient on chronic maintenance of the same class of drugs as an outpatient will not qualify.

When deciding whether to assign high risk, both the drug and the monitoring need to qualify. Doing bi-weekly lab or monthly lab tests, or following in the office every three months is not intensive monitoring.

For some of the medications, the initiation of the treatment may require frequent lab tests, phone calls and office visits. As the patient stabilizes, the frequency of lab tests, calls and visits will decrease. There is no definitive citation to guide a coder or clinician in either the list of drugs or what qualifies as “frequent monitoring.”

In 2021, CPT is revising the definitions for new and established patients, 99202–99215. (99201 will be deleted in 2021.) As part of the revised content that we’ll see in our CPT book in 2021, the AMA has defined drug therapy with intensive monitoring.  You are not required to start using the 2021 definition now, but it is specific and clear, and your group could implement it, if desired.

From the AMA document, describing E/M changes 2021:

“Drug therapy requiring intensive monitoring for toxicity: A drug that requires intensive monitoring is a therapeutic agent that has the potential to cause serious morbidity or death. The monitoring is performed for assessment of these adverse effects and not primarily for assessment of therapeutic efficacy. The monitoring should be that which is generally accepted practice for the agent, but may be patient specific in some cases. Intensive monitoring may be long-term or short term. Long-term intensive monitoring is not less than quarterly. The monitoring may be by a lab test, a physiologic test or imaging. Monitoring by history or examination does not qualify. The monitoring affects the level of medical decision making in an encounter in which it is considered in the management of the patient. Examples may include monitoring for a cytopenia in the use of an antineoplastic agent between dose cycles or the short-term intensive monitoring of electrolytes and renal function in a patient who is undergoing diuresis. Examples of monitoring that does not qualify include monitoring glucose levels during insulin therapy as the primary reason is the therapeutic effect (unless severe hypoglycemia is a current, significant concern); or annual electrolytes and renal function for a patient on a diuretic as the frequency does not meet the threshold.”

This definition reflects the technical corrections issued by the AMA in March, 2021 and is the definition in the 2022 book.

 

Back to Everyday Coding Q&A

 


Get more tips and coding insights from coding expert Betsy Nicoletti.

Subscribe and receive our FREE monthly newsletter and Everyday Coding Q&A.

Sign up

We will never share your email address. Unsubscribe anytime.

Last revised January 2, 2023 - Betsy Nicoletti
Tags: E/M medical decision making

CPT®️️ is a registered trademark of the American Medical Association. Copyright American Medical Association. All rights reserved.

2023 E/M guidelines for hospital, nursing facility, home and residence services | Webinar

Effective January 1, 2023, the AMA has revised the definitions and guidelines for hospital and other E/M services, including ED visits, nursing facility services, home services, and domiciliary care codes. Also, coding for prolonged care services gets another overhaul with revised codes and guidelines. Watch this webinar about all these changes.

Watch it now

Latest Intel

How Physician Services are Paid – Overview

Have a new staff member or practitioner who needs … Read More...

Two visits for the price of one? | Multiple medical visits on the same day

Patients often schedule two medical appointments … Read More...

HCC coding: V24 versus V28

Medical practices are assessing the impact of the … Read More...

CMS’s 2024 shared or split services policy: document and report them correctly

In 2024, CPT expanded its definition of … Read More...

Browse By Categories

Browse Content

  • Articles
  • Coding Guides
  • Everyday Coding Q&A
  • Videos
  • Can I Get Paid to
  • Blog
  • Webinars

Tags

behavioral health_cpt codes behavioral health_medication management care management CMS updates Code sets and reimbursement compliance issues CPT updates critical care services dermatology_essential resource dermatology_modifiers dermatology_procedures E/M frequency data E/M medical decision making E/M overview E/M reference sheets FQHC general surgery_diagnosis coding general surgery_E/M services general surgery_modifiers general surgery_procedures global surgery issues HCC diagnosis coding hospital inpatient/observation ICD-10 coding level of service_history level of service_MDM level of service_time medicare incident-to and shared services minor procedures modifiers newborn care office and other E/M Preventive and problem visits preventive services for medicare primary care_diagnosis coding primary care_essential resource primary care_modifiers primary care_other E/M services primary care_preventive services primary care_procedures prolonged care remote physiologic monitoring screening and counseling for behavioral conditions teaching physician rules telehealth

All content on CodingIntel is copyright protected. Any resource shared within the permissions granted here may not be altered in any way, and should retain all copyright information and logos.

  • What is CodingIntel
  • FAQs
  • Terms of Use
  • Privacy Policy
  • Contact

Our mission is to provide up-to-date, simplified, citation driven resources that empower our members to gain confidence and authority in their coding role.

In 1988, CodingIntel.com founder Betsy Nicoletti started a Medical Services Organization for a rural hospital, supporting physician practice. She has been a self-employed consultant since 1998. She estimates that in the last 20 years her audience members number over 28,400 at in person events and webinars. She has had 2,500 meetings with clinical providers and reviewed over 43,000 medical notes. She knows what questions need answers and developed this resource to answer those questions.

Copyright © 2023, CodingIntel
Privacy Policy